UAB "Lotos pharma"
JAR Code: 302296095
ActiveFinancial Reports
| 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|
| Revenue | 2 121 295 | 1 986 806 | 1 665 695 | 1 826 442 | |
| Profit Before Tax | 431 271 | 281 967 | −85 888 | −217 591 | |
| Net Profit | 362 167 | 232 782 | −85 888 | −217 591 | |
| Profit margin | 17.1% | 11.7% | -5.2% | -11.9% | |
| Equity | 1 276 152 | 1 095 992 | 939 516 | 721 925 | |
| Liabilities | 515 937 | 594 082 | 1 096 952 | 1 126 415 | |
| Total Assets | 1 850 296 | 1 686 429 | 2 042 147 | 1 842 743 |
Financial Reports
2025
Balance Sheet
Total Assets1 842 743 €
Long-term Assets35 928 €
Short-term Assets1 806 815 €
Equity721 925 €
Liabilities1 126 415 €
Profit & Loss Statement
Revenue1 826 442 €
Profit Before Tax−217 591 €
Net Profit−217 591 €
2024
Balance Sheet
Total Assets2 042 147 €
Long-term Assets50 816 €
Short-term Assets1 991 331 €
Equity939 516 €
Liabilities1 096 952 €
Profit & Loss Statement
Revenue1 665 695 €
Profit Before Tax−85 888 €
Net Profit−85 888 €
2023
Balance Sheet
Total Assets1 686 429 €
Long-term Assets18 664 €
Short-term Assets1 667 765 €
Equity1 095 992 €
Liabilities594 082 €
Profit & Loss Statement
Revenue1 986 806 €
Profit Before Tax281 967 €
Net Profit232 782 €
2022
Balance Sheet
Total Assets1 850 296 €
Long-term Assets32 491 €
Short-term Assets1 817 805 €
Equity1 276 152 €
Liabilities515 937 €
Profit & Loss Statement
Revenue2 121 295 €
Profit Before Tax431 271 €
Net Profit362 167 €
2021
Balance Sheet
Total Assets1 298 987 €
Long-term Assets46 317 €
Short-term Assets1 252 670 €
Equity913 984 €
Liabilities390 996 €
Profit & Loss Statement
Revenue1 910 011 €
Profit Before Tax504 483 €
Net Profit426 640 €
2020
Balance Sheet
Total Assets724 853 €
Long-term Assets66 771 €
Short-term Assets658 082 €
Equity487 345 €
Liabilities0 €
Profit & Loss Statement
Revenue1 121 343 €
Profit Before Tax120 181 €
Net Profit100 474 €
2019
Balance Sheet
Total Assets595 205 €
Long-term Assets58 953 €
Short-term Assets536 252 €
Equity386 872 €
Liabilities211 920 €
Profit & Loss Statement
Revenue1 013 623 €
Profit Before Tax111 901 €
Net Profit94 439 €
2018
Balance Sheet
Total Assets524 592 €
Long-term Assets49 836 €
Short-term Assets474 756 €
Equity292 432 €
Liabilities239 793 €
Profit & Loss Statement
Revenue906 695 €
Profit Before Tax108 661 €
Net Profit90 870 €
2017
Balance Sheet
Total Assets590 557 €
Long-term Assets36 760 €
Short-term Assets553 797 €
Equity210 545 €
Liabilities382 243 €
Profit & Loss Statement
Revenue1 045 827 €
Profit Before Tax78 073 €
Net Profit65 986 €
2016
Balance Sheet
Total Assets519 823 €
Long-term Assets61 389 €
Short-term Assets458 434 €
Equity144 559 €
Liabilities387 564 €
Profit & Loss Statement
Revenue837 913 €
Profit Before Tax16 732 €
Net Profit11 681 €
2015
Balance Sheet
Total Assets391 651 €
Long-term Assets86 480 €
Short-term Assets305 171 €
Equity133 225 €
Liabilities258 426 €
Profit & Loss Statement
Revenue597 320 €
Profit Before Tax5 516 €
Net Profit3 481 €
2014
Balance Sheet
Total Assets438 429 €
Long-term Assets99 876 €
Short-term Assets338 553 €
Equity129 613 €
Liabilities308 816 €
Profit & Loss Statement
Revenue528 314 €
Profit Before Tax14 043 €
Net Profit11 548 €
Source: Registrų centras